Skip to main content
SpringerLink
Log in

Genomische Analyse von Melanomen und melanozytären Nävi

Diagnostische Mäglichkeiten und Einblick in die Pathogenese

  • Weiter- und Fortbildung Genomische Analysen
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literaturverzeichnis

  1. Arrington J H, Reed R J, Ichinose H, Krementz ET (1977). Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1, 131–143

    Article  PubMed  Google Scholar 

  2. Bardeesy N, Bastian B C, Hezel A, DePinho R, Chin L (2001). Dual inactivation of RB and P53 pathways in RAS-induced melanomas. Mol Cell Biol 21, 2144–2153

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Bastian BC, Kashani-Sabet M, Hamm H et al. (2000). Gene amplifications characterize acral melanoma and permit the detection of occult cells in the surrounding skin. Cancer Res 60, 1968–1973

    CAS  PubMed  Google Scholar 

  4. Bastian BC, LeBoit PE, Hamm H, Bröcker EB, Pinkel D (1998). Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 58, 2170–2175

    CAS  PubMed  Google Scholar 

  5. Bastian BC, LeBoit PE, Pinkel D (2000). Mutations and copy number increases of HRAS in Spitz nevi with distinctive histopathologic features. Am J Pathol 157, 967–972

    Article  CAS  PubMed  Google Scholar 

  6. Bastian BC, Wesselmann U, Pinkel D, LeBoit PE (1999). Molecular cytogenetic analysis of Spitz nevi show clear differences to melanoma. J Invest Dermatol 113, 1065–1069

    Article  CAS  PubMed  Google Scholar 

  7. Bastian BC, Xiong J, Frieden I J et al. (im Druck). Genetic changes in neoplasms arising in congenital melanocytic nevi: Differences between nodular proliferations and melanomas. Am J Pathol

  8. Brodeur GM, Hogarty MD (1998). Gene amplifications in human cancers: Biological and clinical significance. In The genetic basis of human cancer. Vogelstein B, Kinzler KW (eds). New York, McGraw-Hill

    Google Scholar 

  9. Carr J, Mackie RM (1994). Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol 131, 72–77

    Article  CAS  PubMed  Google Scholar 

  10. Chin L, Merlino G, DePinho RA (1998). Malignant melanoma: modern black plague and genetic black box. Genes Dev 12, 3467–3481

    Article  CAS  PubMed  Google Scholar 

  11. Chin L, Tam A, Pomerantz J et al. (1999). Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468–472

    Article  CAS  PubMed  Google Scholar 

  12. Farmer ER, Gonin R., Hanna MP (1996). Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 27, 528–531

    Article  CAS  PubMed  Google Scholar 

  13. Florenes VA, Faye RS, Maelandsmo G M, Nesland JM, Holm R (2000). Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma [In Process Citation]. Clin Cancer Res 6, 3614–3620

    CAS  PubMed  Google Scholar 

  14. Hanahan D, Weinberg R A (2000). The hallmarks of cancer. Cell 100, 57–70

    Article  CAS  PubMed  Google Scholar 

  15. Harvell JD, Bastian BC, LeBoit PE (2002). Persistent (recurrent) Spitz nevi: A histopathologic, immunohistochemical and molecular pathologic study of 22 cases. Am J Surg Pathol 26, 654–661

    Article  PubMed  Google Scholar 

  16. Healy E, Belgaid CE, Takata, M et al. (1996). Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res 56, 589–593

    CAS  PubMed  Google Scholar 

  17. Herbst RA, Mommert S, Casper U et al. (2000). 11q23 allelic loss is associated with regional lymph node metastasis in melanoma [In Process Citation]. Clin Cancer Res 6, 3222–3227

    CAS  PubMed  Google Scholar 

  18. Herlyn M, Satyamoorthy, K (1996). Activated ras. Yet another player in melanoma? Am J Pathol 149, 739–744

    CAS  PubMed  Google Scholar 

  19. Kallioniemi A, Kallioniemi OP, Sudar D et al. (1992). Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818–821

    Article  CAS  PubMed  Google Scholar 

  20. Lengauer C, Kinzler KW, Vogelstein G (1998). Genetic instabilities in human cancers. Nature 396, 643–649

    Article  CAS  PubMed  Google Scholar 

  21. Mathon NF, Lloyd AC (2001). Cell senescence and cancer. Nat Rev Cancer 1, 203–213

    Article  CAS  PubMed  Google Scholar 

  22. McGovern VJ, Mihm MC, Jr, Bailly C et al. (1973). The classification of malignant melanoma and its histologic reporting. Cancer 32, 1446–1457

    Article  CAS  PubMed  Google Scholar 

  23. Myung K, Datta A, Kolodner RD (2001). Suppression of spontaneous chromosomal rearrangements by S phase checkpoint functions in Saccharomyces cerevisiae. Cell 104, 397–408

    Article  CAS  PubMed  Google Scholar 

  24. Park WS, Vortmeyer AO, Pack S et al. (1998). Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus. Hum Pathol 29, 127–230

    Article  CAS  PubMed  Google Scholar 

  25. Pollock PM, Hayward N (2002). Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines. Melanoma Res 12, 183–186

    Article  CAS  PubMed  Google Scholar 

  26. Ramirez RD, D'Atri S, Pagani E et al. (1999). Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia 1, 42–49

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Sauter ER, Yeo UC, von Stemm A et al. (in press) Cyclin D1 is a Candidate Oncogene in Cutaneous Melanoma. Cancer Res

  28. Sherr CJ, Roberts JM (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13, 1501–1512

    Article  CAS  PubMed  Google Scholar 

  29. Veenhuizen KC, De Wit PE, Mooi WJ, Scheffer E, Verbeek AL, Ruiter DJ (1997). Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party [see comments]. J Pathol 182, 266–22

    Article  CAS  PubMed  Google Scholar 

  30. Weyers W, Euler M, Diaz-Cascajo C, Schill WB, Bonczkowitz M (1999). Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types. Cancer 86, 288–299

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Dermatology and Pathology and UCSF Comprehensive Cancer Center University of California, San Francisco, 2340 Sutter Street, Room S434, 94115, San Francisco, CA, USA

    B. C. Bastian

Authors
  1. B. C. Bastian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. C. Bastian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bastian, B. Genomische Analyse von Melanomen und melanozytären Nävi. Hautarzt 53, 499–509 (2002). https://doi.org/10.1007/s00105-002-0406-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-002-0406-0

Search

Navigation